Abstract:Objective To investigate the diagnostic value of ADC for breast lesions with different enhancement shape or mass size. Methods One hundred and thirty-six breast lesions confirmed by histopathology were included in this study. According to enhancement shape and size of the lesion, all lesions were divided into 3 groups: non-masslike enhancement ( G1 ), masslike enhancement with the largest diameter ＜ 2. 0 cm (G2a) and masslike enhancement with the largest diameter ＞ 2. 0 cm (G2b). Echo planar imaging DWI was performed and three b-values (0,500 and 1000 s/mm2) were applied. The t-test was used for testing the difference of ADC between malignant and non-malignant breast lesions in each group. ROC curve was deduced to test the diagnostic efficiency of ADC. The sensitivity, specificity, negative predictive value( NPV), positive predictive value(PPV) and accuracy of ADC for the diagnosis of breast lesions were calculated under the different threshold. Appropriate b value and threshold were determined with the combination of morphologic evaluation. Results There were no significant differences for the mean ADC values between malignant [b =800 mm2/s: ADC value = ( 1.13 ±0. 23) × 10-3 mm2/s,b=1000 mm2/s: ADC value = (1.05 ±0.20) × 10-3 mm2/s] and non-malignant breast lesions [b =800 mm2/s: ADC value = ( 1.28 ±0. 27) × 10-3 mm2/s, t = 1. 636, P =0. 112,b = 1000 mm2/s: ADC value=(1.20 ±0.23) × 10-3 mm2/s, t = 1.720, P =0. 109] in Group 1. The mean ADC values of malignant breast lesion [b =800 mm2/s: ADC value = (1.07 ±0. 15) × 10-3 mm2/s,b = 1000 mm2/s:ADC value = (0. 99 ±0. 14) × 10-3 mm2/s] were significantly lower than that of non-malignant lesion [b =800 mm2/s: ADC value = ( 1.37 ± 0. 37 ) × 10-3 mm2/s, t = 4. 803, P = 0. 000; b = 1000 mm2/s: ADC value= (1.30 ±0.34) × 10-3 mm2/s, t =4.227, P =0.000] in Group 2a. The mean ADC values of malignant breast lesion [b =800 mm2/s: ADC value = (0. 97 ±0. 14) × 10-3 mm2/s; b = 1000 mm2/s:ADC value = (0. 93 ±0. 14) × 10-3 mm2/s] were significantly lower than that of non-malignant lesion [b =800 mm2/s: ADC value = ( 1.40 ± 0. 39) × 10 -3 mm2/s, t = 4. 227, P = 0. 000; b = 1000 mm2/s: ADC value = ( 1.35 ±0. 36) × 10-3 mm2/s, t =4. 329, P =0. 000] in Group 2b. The diagnostic efficiency was equal( x2 =0. 36,P =0. 5460) whenever b value of 800 or 1000 s/mm2 was selected. The highest sensitivity (97.7%) and NPV (97. 1%) were obtained with b value of 1000 s/mm2 and threshold of 1.25 ×10 -3 s/mm2. Conclusion MR DWI is useful for the differential diagnosis of breast lesions with masslike enhancement rather than nonmasslike enhancement.

Diffusion-weighted MR Imaging in Seminal Vesicle Gland

Diffusion Weighted Imaging and Apparent Diffusion Coefficient Value in Differential Diagnosis of Lymph Node Lesions

Prostatic Abscess and Seminal Vesicle Abscess: MRI Findings and Quantitative Analysis of Apparent Diffusion Coefficient Values

Diagnosis value of apparent diffusion coefficient of magnetic resonance imaging in grading of prostate cancer

Differentiation of benign and malignant lesions of the prostate by MR diffusion weighted imaging

Diffusion-weighted MR imaging of the prostate:preliminary study

Correlation Between Diffusion-Weighted MR Imaging and Gleason Score of Prostate Cancer

Diffusion-weighted Imaging in Differential Dignosis of Incidentally Detected Prostate Carcinoma in the Central Gland from Benign Prostate Hyperplasia

Diffusion-weighted imaging of prostate cancer on 3T MR: Relationship between apparent diffusion coefficient values and Ki-67 expression.

Diagnostic criterion of diffusion-weighted imaging for prostatic peripheral zone cancer

Quantitative Analysis of Benign Prostatic Hyperplasia with Apparent Diffusion Coefficient

Diagnosis of Diffusion-Weighted Imaging for Prostatic Central Gland Cancer

Diffusion Weighted MR Imaging of Prostate Adenocarcinoma after Endocrinotherapy:Influence of B Value

MR Spectroscopy and Diffusion Weighted Imaging of Prostatic Central Gland Cancer and Analysis of Misdiagnosis

Value of Apparent Diffusion Coefficient in MR Diffusion-Weighted Imaging for Differential Diagnosis of Benign and Malignant Musculoskeletal Tumors

MR diffusion weighted imaging of the prostate adenocarcinoma after endocrinotherapy:preliminary results

The Effect of Different b-values on the Apparent Diffusion Coefficient and DADC in Prostate Cancerous and Non-cancerous Regions

MR diffusion-weighted imaging in differential diagnosis of breast lesions with different enhancement shapes or size and parameter selection

Assessment of diffusion-weighted MR imaging for pelvic lymph node in patients with prostate cancer:a preliminary study

Normal Appearance of Large Field Diffusion Weighted Imaging on 3.0T MRI

Preoperative Evaluation of the Association of ADC with Diffusion-Weighted Imaging and PSA in Prostate Cancer